188 related articles for article (PubMed ID: 22067884)
1. Modelling the cost-effectiveness of electric stimulation therapy in non-healing venous leg ulcers.
Taylor RR; Sladkevicius E; Guest JF
J Wound Care; 2011 Oct; 20(10):464, 466, 468-72. PubMed ID: 22067884
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes and cost-effectiveness of an externally applied electroceutical device in managing venous leg ulcers in clinical practice in the UK.
Guest JF; Ayoub N; Greaves T
J Wound Care; 2015 Dec; 24(12):572, 574-80. PubMed ID: 26654737
[TBL] [Abstract][Full Text] [Related]
3. Modelling the relative cost-effectiveness of amelogenin in non-healing venous leg ulcers.
Guest JF; Nagy E; Sladkevicius E; Vowden P; Price P
J Wound Care; 2009 May; 18(5):216, 218-24. PubMed ID: 19440174
[TBL] [Abstract][Full Text] [Related]
4. Relative cost-effectiveness of a skin protectant in managing venous leg ulcers in the UK.
Guest JF; Taylor RR; Vowden K; Vowden P
J Wound Care; 2012 Aug; 21(8):389-94, 396-8. PubMed ID: 22885312
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes and cost-effectiveness of three alternative compression systems used in the management of venous leg ulcers.
Guest JF; Gerrish A; Ayoub N; Vowden K; Vowden P
J Wound Care; 2015 Jul; 24(7):300, 302-5, 307-8, passim. PubMed ID: 26198552
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of using a collagen-containing dressing plus compression therapy in non-healing venous leg ulcers.
Guest JF; Rana K; Singh H; Vowden P
J Wound Care; 2018 Feb; 27(2):68-78. PubMed ID: 29424641
[TBL] [Abstract][Full Text] [Related]
7. Modelling the cost-utility of bio-electric stimulation therapy compared to standard care in the treatment of elderly patients with chronic non-healing wounds in the UK.
Clegg JP; Guest JF
Curr Med Res Opin; 2007 Apr; 23(4):871-83. PubMed ID: 17407644
[TBL] [Abstract][Full Text] [Related]
8. Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs.
Panca M; Cutting K; Guest JF
J Wound Care; 2013 Mar; 22(3):109-10, 112-8. PubMed ID: 23665729
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of an electroceutical device in treating non-healing venous leg ulcers: results of an RCT.
Guest JF; Singh H; Rana K; Vowden P
J Wound Care; 2018 Apr; 27(4):230-243. PubMed ID: 29637824
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes and cost-effectiveness of three different compression systems in newly-diagnosed venous leg ulcers in the UK.
Guest JF; Fuller GW; Vowden P
J Wound Care; 2017 May; 26(5):244-254. PubMed ID: 28475441
[TBL] [Abstract][Full Text] [Related]
11. Relative cost-effectiveness of three compression bandages in treating newly diagnosed venous leg ulcers in the UK.
Guest JF; Fuller GW
J Wound Care; 2023 Mar; 32(3):146-158. PubMed ID: 36930185
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of using intermittent pneumatic compression to manage hard-to-heal venous leg ulcers in the UK.
Guest JF; Staines K; Murphy N
J Wound Care; 2021 Jul; 30(7):544-552. PubMed ID: 34256598
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers.
Carter MJ; Waycaster C; Schaum K; Gilligan AM
Value Health; 2014 Dec; 17(8):801-13. PubMed ID: 25498775
[TBL] [Abstract][Full Text] [Related]
14. Venous leg ulcer management in clinical practice in the UK: costs and outcomes.
Guest JF; Fuller GW; Vowden P
Int Wound J; 2018 Feb; 15(1):29-37. PubMed ID: 29243398
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK.
Guest JF; Deanesi V; Segalla A
J Wound Care; 2022 Jun; 31(6):480-491. PubMed ID: 35678784
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness analysis of guideline-based optimal care for venous leg ulcers in Australia.
Cheng Q; Gibb M; Graves N; Finlayson K; Pacella RE
BMC Health Serv Res; 2018 Jun; 18(1):421. PubMed ID: 29880046
[TBL] [Abstract][Full Text] [Related]
17. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of two reduced pressure compression systems in treating newly diagnosed venous leg ulcers.
Guest JF; Fuller GW
J Wound Care; 2023 Jun; 32(6):348-358. PubMed ID: 37300861
[TBL] [Abstract][Full Text] [Related]
19. Estimating the Clinical Outcomes and Cost Differences Between Standard Care With and Without Cadexomer Iodine in the Management of Chronic Venous Leg Ulcers Using a Markov Model.
Nherera LM; Woodmansey E; Trueman P; Gibbons GW
Ostomy Wound Manage; 2016 Jun; 62(6):26-40. PubMed ID: 27356144
[TBL] [Abstract][Full Text] [Related]
20. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers.
Schonfeld WH; Villa KF; Fastenau JM; Mazonson PD; Falanga V
Wound Repair Regen; 2000; 8(4):251-7. PubMed ID: 11013015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
